Calvert Formula, MDRD with urine
GFR, MDRD
Calvert formula: Calculates carboplatin dose by linking target AUC to GFR.
MDRD with urine: Estimates GFR using serum creatinine together with urine creatinine and urine flow.
Sex
Female+0.822Male+1
Race
Other Race+1African American+1.178
mg/dL
g/day
mg/dL
mg/(mL*min)
yo.
Indications for Use
Used to individualize carboplatin dosing when an accurate GFR is needed; apply when kidney‑cleared chemotherapy has a narrow therapeutic index or risk of toxicity. eGFRcr‑cys improves dosing accuracy over eGFRcr alone in cancer patients 1 [Level II evidence]. MDRD with urine (timed CrCl) is reserved only when mGFR is unavailable and eGFRcr‑cys is unreliable, per KDIGO Practice Point 1.2.2.8 2 [Level I evidence].
Insights & Cautions
Use accurate GFR because dosing error is clinically significant.
- Calvert: Risk of overdose if creatinine is enzymatic and unadjusted; consider adding +0.2 mg/dL to creatinine to avoid severe thrombocytopenia 1 [Level II evidence]. In cancer, eGFRcr‑cys is most accurate for carboplatin dosing and reduces 10–20% overdose risk vs eGFRcr alone 2 [Level II evidence].
- MDRD with urine: Timed urine CrCl is highly error‑prone with ~25% mean bias; under‑ and over‑collection each seen in 25% of patients 3 [Level I evidence]. Use only if supervised; otherwise prefer cystatin‑C–based eGFR or mGFR when accuracy is critical.